Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
25 hedge funds and large institutions have $3.93M invested in Tetraphase Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 6 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
102% more capital invested
Capital invested by funds: $1.94M → $3.93M (+$1.99M)
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
9% more funds holding
Funds holding: 23 → 25 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$2.59M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.36M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$510K |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$425K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$61.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$174K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$80K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$32K |
| 4 |
Two Sigma Advisers
New York
|
-$30K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.1K |
TTPH Hedge Fund Activity: Q1 2020 in Review
25 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q1 2020, worth a combined $3.93M — up 102% from $1.94M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TTPH positions and 6 closed out — a net gain of 3 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Armistice Capital, adding an estimated $2.59M. The largest seller was Russell Investments Group, exiting entirely with an estimated $174K sold.
- 25 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q1 2020, up from 23 in Q4 2019.
- Funds reported $3.93M of Tetraphase Pharmaceuticals, Inc. stock for Q1 2020, up 102% quarter-over-quarter.
- 9 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q1 2020 and 6 closed out, a net change of +3 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q1 2020 was Armistice Capital, an estimated $2.59M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q1 2020 was Russell Investments Group, an estimated $174K sold.
Based on aggregated 13F filings for Q1 2020.